Back to Index
S Winer, MD, MPH
Clinical Professor of Obstetrics & Gynecology (Part Time)
Co Director, Rei Clinic
Obstetrics & Gynecology
IRD 530 Off Campus Los Angeles
+1 323 226 3026


Effect of hormone therapy on breast epithelial cell proliferation. Menopause. 2013 May; 20(5):483-5. View in: PubMed

Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev. 2013 Apr; 34(2):171-208. View in: PubMed

Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness. Expert Rev Pharmacoecon Outcomes Res. 2009 Apr; 9(2):157-70. View in: PubMed

The pharmacologic management of premenstrual dysphoric disorder. Expert Opin Pharmacother. 2008 Feb; 9(3):429-45. View in: PubMed

Drospirenone/ethinyl estradiol. Drugs Today (Barc). 2008 Feb; 44(2):133-45. View in: PubMed

Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder. Womens Health (Lond Engl). 2007 Jul; 3(4):395-408. View in: PubMed

Drospirenone: a novel progestin. Expert Opin Pharmacother. 2007 May; 8(7):989-99. View in: PubMed

Premenstrual disorders: prevalence, etiology and impact. J Reprod Med. 2006 Apr; 51(4 Suppl):339-47. View in: PubMed

Powered bySC CTSI